BCMIO
DGX icon

Beacon Capital Management Inc (Ohio)’s Quest Diagnostics DGX Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed – – 99
2017
Q1 		$0 Buy
+1
New +$95 ﹤0.01% 102

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s DGX Position: Q2 2017 in Review

Beacon Capital Management Inc (Ohio) sold out of Quest Diagnostics (DGX) in Q2 2017, closing a stake of 1 share.

Beacon Capital Management Inc (Ohio) first reported a position in DGX in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Beacon Capital Management Inc (Ohio) reported no remaining Quest Diagnostics position as of Q2 2017 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 1 Quest Diagnostics share in Q2 2017.
  • Beacon Capital Management Inc (Ohio) first reported a position in Quest Diagnostics in Q1 2017 and held it in 1 quarter.
  • Beacon Capital Management Inc (Ohio)'s Quest Diagnostics position peaked at $0 in Q1 2017.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2017, filed 11 Jul 2017.